THOMSON, ROGERS has issued a national Class Action lawsuit on behalf of Canadians with Parkinson's disease and/or Restless Leg Syndrome who allege to have developed compulsive behaviour, including a pathological gambling addiction, as a result of their use of the drug Mirapex, a dopamine agonist. The Class Action claim seeks millions of dollars in compensation from the Canadian drug manufacturer, Boehringer Ingelheim (Canada) Ltd., and two American corporations.
Please note that anyone who started taking Mirapex AFTER July 27, 2012 is not eligible to participate in the class action (as they do not fall within the Court approved definition of a 'class member')--those persons may wish to consult with a lawyer in relation to any claims they may have.
|An update regarding the outcome of the mediation in June of 2014 will be posted here within the next few weeks. Please wait patiently for that update.|
|A mediation in this matter has now been scheduled to take place on June 24 and June 25, 2014. We anticipate being able to provide information regarding the outcome of the mediation in early July.|
The parties will be meeting near the end of November, 2013 to discuss these claims. A further update will follow thereafter.
The deadline for the submission of Questionnaires under the Negotiation Process has now past.
We are in the process of sharing the information that has been received from class members with the lawyers for the defendant.
We expect to have meetings with the defence lawyers over the next several months to discuss the possibility of a negotiated resolution.
We intend to send an update letter to class members at the end of August, 2013 and ask that you wait for our letter rather than call for updates.
We will also post any public update information here as well.
MIRAPEX CLASS ACTION CERTIFIED - NEGOTIATION PROCESS AGREED TO BETWEEN THE PARTIES
We are pleased to announce the Certification of the Mirapex class action by Order of the Honourable Justice Strathy dated July 27, 2012.
We are also pleased to announce the agreement between the parties to develop a Negotiation Process aimed at determining whether the claims of Class Members can potentially be resolved without further litigation.
If you are a person resident in Canada (other than Quebec) who was prescribed and ingested the drug Mirapex prior to July 27, 2012 (a "Class Member") and claim, as a result, to have suffered damages relating to an impulse control disorder (meaning pathological gambling, hyper-sexuality, compulsive shopping and/or binge eating) we strongly encourage you to participate in the Negotiation Process.
To participate in the Negotiation Process, you must submit a completed Negotiation Process Questionnaire to Thomson, Rogers, by Wednesday, February 27, 2013.
Below you will find the following important documents:
If you intend to participate in the Negotiation Process and have not already been in contact with us at Thomson, Rogers please contact us at 1-888-223-0448 for further information.
For more information.
If you’d like to learn more about this class action, please contact Darcy Merkur via e-mail or through our toll-free number 1-888-223-0448. Locally, in the Toronto area, you may call 416-868-3176.
If you are a user of Mirapex and wish to support the Class Action and be included in our Mirapex Class Action database, please fill out the form below.
PLEASE NOTE: FOR CANADIAN (NON QUEBEC) RESIDENTS ONLY.
Residents of Quebec should contact Andre Lesperance, A Quebec lawyer, at 514-844-6958 to discuss your potential claim.